Company’s 36-month beta value is 1.80.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for NPCE is 13.42M, and currently, short sellers hold a 3.26% ratio of that floaft. The average trading volume of NPCE on November 14, 2024 was 70.05K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NPCE) stock’s latest price update
NeuroPace Inc (NASDAQ: NPCE)’s stock price has gone rise by 28.15 in comparison to its previous close of 7.14, however, the company has experienced a 17.31% increase in its stock price over the last five trading days. seekingalpha.com reported 2024-11-12 that NeuroPace, Inc. (NASDAQ:NPCE ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Jeremy Feffer – Investor Relations Joel Becker – Chief Executive Officer Rebecca Kuhn – Chief Financial Officer Conference Call Participants Frank Takkinen – Lake Street Capital Markets Mike Kratky – Leerink Partners Vik Chopra – Wells Fargo Ross Osborn – Cantor Fitzgerald Michael Polark – Wolfe Research Operator Greetings and welcome to NeuroPace’s Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
NPCE’s Market Performance
NPCE’s stock has risen by 17.31% in the past week, with a monthly rise of 41.64% and a quarterly rise of 28.96%. The volatility ratio for the week is 13.52% while the volatility levels for the last 30 days are 9.74% for NeuroPace Inc The simple moving average for the past 20 days is 34.87% for NPCE’s stock, with a -5.19% simple moving average for the past 200 days.
Analysts’ Opinion of NPCE
Many brokerage firms have already submitted their reports for NPCE stocks, with Wells Fargo repeating the rating for NPCE by listing it as a “Overweight.” The predicted price for NPCE in the upcoming period, according to Wells Fargo is $20 based on the research report published on March 14, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see NPCE reach a price target of $22. The rating they have provided for NPCE stocks is “Outperform” according to the report published on January 30th, 2024.
Cantor Fitzgerald gave a rating of “Overweight” to NPCE, setting the target price at $11 in the report published on November 10th of the previous year.
NPCE Trading at 33.78% from the 50-Day Moving Average
After a stumble in the market that brought NPCE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.59% of loss for the given period.
Volatility was left at 9.74%, however, over the last 30 days, the volatility rate increased by 13.52%, as shares surge +42.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +28.87% upper at present.
During the last 5 trading sessions, NPCE rose by +17.31%, which changed the moving average for the period of 200-days by -39.00% in comparison to the 20-day moving average, which settled at $6.78. In addition, NeuroPace Inc saw -11.25% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NPCE starting from KCK LTD., who sale 223,991 shares at the price of $5.45 back on Oct 25 ’24. After this action, KCK LTD. now owns 5,270,845 shares of NeuroPace Inc, valued at $1,221,042 using the latest closing price.
KCK LTD., the 10% Owner of NeuroPace Inc, sale 147 shares at $6.02 during a trade that took place back on Oct 23 ’24, which means that KCK LTD. is holding 5,494,836 shares at $885 based on the most recent closing price.
Stock Fundamentals for NPCE
Current profitability levels for the company are sitting at:
- -0.3 for the present operating margin
- 0.74 for the gross margin
The net margin for NeuroPace Inc stands at -0.3. The total capital return value is set at -0.28. Equity return is now at value -214.55, with -28.72 for asset returns.
Based on NeuroPace Inc (NPCE), the company’s capital structure generated 0.88 points at debt to capital in total, while cash flow to debt ratio is standing at -0.22. The debt to equity ratio resting at 7.48. The interest coverage ratio of the stock is -5.15.
Currently, EBITDA for the company is -22.83 million with net debt to EBITDA at -3.07. When we switch over and look at the enterprise to sales, we see a ratio of 4.25. The receivables turnover for the company is 6.61for trailing twelve months and the total asset turnover is 0.79. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.59.
Conclusion
In a nutshell, NeuroPace Inc (NPCE) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.